• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Samsung Bioepis secures positive CHMP opinion for Aybintio pharmaceutical-technology
    June 28, 2020
    Korean biopharmaceutical firm Samsung Bioepis has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for Aybintio, a biosimilar to Avastin (bevacizumab).

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service